Qiagen N.V. Financial Ratios
NYSE: QGENHealthcareDiagnostics & ResearchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Qiagen N.V. ratio analysis
Qiagen N.V. earned a net margin of 20.3% in FY 2025, up from 4.2% a year earlier. Gross margin was 62.2% compared with a median of 64.7% over the prior 9 years. Return on equity reached 11.2%, meaning Qiagen N.V. generated 0.11 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.44 versus 0.39 the year before, and the current ratio was 3.90. At the end of FY 2025, QGEN traded at 23.3 times earnings; across the 9 fiscal years shown, its year-end P/E ranged from 23.3 to 187.8, with a median of 35.6. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Qiagen N.V. financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 23.29 | 121.54 | 30.28 | 27.97 | 25.95 | 35.65 | — | 43.85 | 187.76 | 88.41 |
| Price / sales | 4.70 | 5.06 | 5.20 | 5.47 | 5.81 | 6.66 | 5.21 | 5.43 | 5.14 | 5.27 |
| Price / book | 2.60 | 2.81 | 2.69 | 3.38 | 4.22 | 4.45 | 3.13 | 3.09 | 2.87 | 2.71 |
| Gross margin | 62.2% | 48.9% | 62.8% | 64.7% | 64.4% | 65.9% | 65.9% | 66.6% | 65.1% | 63.1% |
| Operating margin | 22.3% | 4.9% | 20.9% | 24.8% | 28.0% | 20.7% | -1.7% | 17.8% | 10.8% | 7.4% |
| Net margin | 20.3% | 4.2% | 17.4% | 19.8% | 22.8% | 19.2% | -2.7% | 12.7% | 2.8% | 6.0% |
| Free cash flow margin | 21.7% | 25.6% | 15.8% | 27.4% | 19.9% | 17.4% | 13.9% | 16.6% | 13.9% | 20.0% |
| Return on equity (ROE) | 11.2% | 2.3% | 9.0% | 12.2% | 16.6% | 12.8% | -1.6% | 7.2% | 1.6% | 3.1% |
| Return on assets (ROA) | 6.8% | 1.5% | 5.6% | 6.7% | 8.3% | 6.1% | -0.8% | 3.3% | 0.8% | 1.9% |
| Debt / equity | 0.44 | 0.39 | 0.40 | 0.54 | 0.63 | 0.69 | 0.67 | 0.83 | 0.69 | 0.41 |
| Current ratio | 3.90 | 1.88 | 1.99 | 2.46 | 1.39 | 2.84 | 1.65 | 2.22 | 5.07 | 3.36 |
| Revenue growth | 5.7% | 0.7% | -8.2% | -4.9% | 20.4% | 22.5% | 1.6% | 5.9% | 5.9% | 4.5% |
| EPS growth | 424.3% | -75.0% | -19.6% | -16.7% | 44.4% | — | -122.0% | 382.4% | -50.0% | -38.2% |